Last Name First Name Research/Clinical Interest Title Keywords   MANNE UPENDER Translational research in grastrointestinal malignancies and breast cancer Colorectal Cancer, GI malignancies, Breast Cancer, Molecular Biomarkers, Ancestry Differences, Population-based Studies, ancer Control & Prevention   MANNE UPENDER Translational research in grastrointestinal malignancies and breast cancer Colorectal Cancer, GI malignancies, Breast Cancer, Molecular Biomarkers, Ancestry Differences, Population-based Studies, ancer Control & Prevention   MANNE UPENDER Translational research in grastrointestinal malignancies and breast cancer Colorectal Cancer, GI malignancies, Breast Cancer, Molecular Biomarkers, Ancestry Differences, Population-based Studies, ancer Control & Prevention   MANNE UPENDER Translational research in grastrointestinal malignancies and breast cancer Colorectal Cancer, GI malignancies, Breast Cancer, Molecular Biomarkers, Ancestry Differences, Population-based Studies, ancer Control & Prevention   MARK VICTOR Associate Professor aphasia, unilateral spatial neglect, executive dysfunction, Constraint-Induced Movement Therapy, paralysis, stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, rehabilitation, physical therapy, occupational therapy, speech   MARK VICTOR Associate Professor aphasia, unilateral spatial neglect, executive dysfunction, Constraint-Induced Movement Therapy, paralysis, stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, rehabilitation, physical therapy, occupational therapy, speech   MARK VICTOR Associate Professor aphasia, unilateral spatial neglect, executive dysfunction, Constraint-Induced Movement Therapy, paralysis, stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, rehabilitation, physical therapy, occupational therapy, speech   MARK VICTOR Associate Professor aphasia, unilateral spatial neglect, executive dysfunction, Constraint-Induced Movement Therapy, paralysis, stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, rehabilitation, physical therapy, occupational therapy, speech   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MARKERT JAMES Engineering Herpes Simplex Viruses for the Therapy of Cancer glioma, gene therapy, brain tumors, herpes simplex, cancer therapy, immunotherapy, anti-angiogenic therapy   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MATALON SADIS Free Radical Protection from and Exacerbation of Lung Injury Acute Lung Injury, pulmonary edema, pulmonary surfactant, alveolar epithelium, free radicals, nitric oxide, sodium channels   MAYNARD CRAIG Intestinal Immune Regulation in Health and Disease immunoregulation, microbiota, inflammatory bowel disease (IBD), regulatory T cells, anti-commensal antibodies   MAYNARD CRAIG Intestinal Immune Regulation in Health and Disease immunoregulation, microbiota, inflammatory bowel disease (IBD), regulatory T cells, anti-commensal antibodies   MAYNARD CRAIG Intestinal Immune Regulation in Health and Disease immunoregulation, microbiota, inflammatory bowel disease (IBD), regulatory T cells, anti-commensal antibodies   MCELDERRY HUGH Electrophysiology, Ventricular Tachycardia, Atrial Fibrillation, Pre-clinical Ablation Catherter Research   MCNICHOLAS-BEVENSEE CARMEL Regulation of ion channels Ion channel, Pulmonary, Cardiovascular, Sweat gland   MCNICHOLAS-BEVENSEE CARMEL Regulation of ion channels Ion channel, Pulmonary, Cardiovascular, Sweat gland   MESTECKY JIRI Mucosal Immunity; Vaccines   MESTECKY JIRI Mucosal Immunity; Vaccines   MESTECKY JIRI Mucosal Immunity; Vaccines   MESTECKY JIRI Mucosal Immunity; Vaccines   MESTECKY JIRI Mucosal Immunity; Vaccines   MESTECKY JIRI Mucosal Immunity; Vaccines   MESTECKY JIRI Mucosal Immunity; Vaccines   MESTECKY JIRI Mucosal Immunity; Vaccines   MESTECKY JIRI Mucosal Immunity; Vaccines   MESTECKY JIRI Mucosal Immunity; Vaccines   MESTECKY JIRI Mucosal Immunity; Vaccines   MESTECKY JIRI Mucosal Immunity; Vaccines   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MICHALEK SUZANNE Immunological mechanisms involved in host/microbial interactions, and development of mucosal vaccines against infectious agents mucosal vaccines, inflammation, TLRs, T cell, cytokines, signaling pathways   MILLER C. RYAN Glioma pathogenesis and preclinical experimental therapeutics glioma, glioblastoma, mouse models, genomics, proteomics   MILLER C. RYAN Glioma pathogenesis and preclinical experimental therapeutics glioma, glioblastoma, mouse models, genomics, proteomics   MILLER C. RYAN Glioma pathogenesis and preclinical experimental therapeutics glioma, glioblastoma, mouse models, genomics, proteomics   MILLER C. RYAN Glioma pathogenesis and preclinical experimental therapeutics glioma, glioblastoma, mouse models, genomics, proteomics   MILLER C. RYAN Glioma pathogenesis and preclinical experimental therapeutics glioma, glioblastoma, mouse models, genomics, proteomics   MILLER C. RYAN Glioma pathogenesis and preclinical experimental therapeutics glioma, glioblastoma, mouse models, genomics, proteomics   MILLER C. RYAN Glioma pathogenesis and preclinical experimental therapeutics glioma, glioblastoma, mouse models, genomics, proteomics   MILLER C. RYAN Glioma pathogenesis and preclinical experimental therapeutics glioma, glioblastoma, mouse models, genomics, proteomics First Prev   24 25 26 27 28 29 30 31 32 33 of  47  Next Last